Matthew (matt) Kennedy PhD

Matt has spent the majority of his nearly 20-year career in drug discovery searching for a cure to one of the most challenging diseases, Alzheimer’s. He played a key role in the discovery of a medicine that targets plaque formation in Alzheimer’s patients, and he currently leads a team of drug discovery scientists working to develop new treatments for Parkinson’s and ALS, in addition to Alzheimer’s. He also spends a portion of his time mentoring young scientists who he believes will lead our generation to a cure for these challenging neurological diseases.